Frank R. Jimenez Buys 1,315 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) insider Frank R. Jimenez bought 1,315 shares of GE HealthCare Technologies stock in a transaction on Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares in the company, valued at $5,799,909.92. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.

GE HealthCare Technologies Trading Up 2.1 %

NASDAQ GEHC opened at $79.47 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The business has a fifty day simple moving average of $88.44 and a 200 day simple moving average of $78.81. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The firm has a market capitalization of $36.27 billion, a P/E ratio of 22.76, a PEG ratio of 2.72 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting the consensus estimate of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The company had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the prior year, the company posted $0.85 earnings per share. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on GEHC shares. HSBC started coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 price objective for the company. Argus increased their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Citigroup increased their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Finally, UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $95.00.

Hedge Funds Weigh In On GE HealthCare Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of GEHC. Wynn Capital LLC boosted its position in GE HealthCare Technologies by 4.1% in the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after purchasing an additional 122 shares during the last quarter. Byrne Asset Management LLC raised its position in GE HealthCare Technologies by 0.8% in the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after acquiring an additional 126 shares during the period. WASHINGTON TRUST Co boosted its stake in GE HealthCare Technologies by 7.7% in the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock valued at $168,000 after acquiring an additional 133 shares during the last quarter. Fiduciary Trust Co grew its position in shares of GE HealthCare Technologies by 1.8% during the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after acquiring an additional 133 shares during the period. Finally, Quent Capital LLC increased its stake in shares of GE HealthCare Technologies by 21.3% during the 1st quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.